![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RAI14 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1314270 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAI14 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1314270 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAI14 mRNA | CTD | PMID:17942748 | 17beta-estradiol | affects expression | ISO | RGD:1314269 | 6480464 | Estradiol affects the expression of RAI14 mRNA | CTD | PMID:14699072 | 17beta-estradiol | increases expression | ISO | RGD:1314269 | 6480464 | Estradiol results in increased expression of RAI14 mRNA | CTD | PMID:19619570 more ... | 17beta-estradiol | multiple interactions | ISO | RGD:1314269 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of RAI14 mRNA more ... | CTD | PMID:19619570 more ... | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1314269 | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1314269 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAI14 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAI14 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1314270 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAI14 mRNA | CTD | PMID:27913140 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1314270 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAI14 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1314270 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAI14 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314270 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314269 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA | CTD | PMID:19619570 | 2,4,6-tribromophenol | increases expression | ISO | RGD:1314269 | 6480464 | 2 more ... | CTD | PMID:31675489 | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | RGD:1314269 | 6480464 | tetrabromobisphenol A results in increased expression of RAI14 protein | CTD | PMID:31675489 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1314270 | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of RAI14 mRNA | CTD | PMID:20188158 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of RAI14 mRNA | CTD | PMID:22504374 more ... | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of RAI14 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:1314269 | 6480464 | Aflatoxin B1 results in increased expression of RAI14 mRNA | CTD | PMID:22100608 | aflatoxin B1 | increases methylation | ISO | RGD:1314269 | 6480464 | Aflatoxin B1 results in increased methylation of RAI14 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1314269 | 6480464 | Tretinoin results in decreased expression of RAI14 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | increases expression | ISO | RGD:1314269 | 6480464 | Tretinoin results in increased expression of RAI14 mRNA | CTD | PMID:23830798 | aristolochic acid A | decreases expression | ISO | RGD:1314269 | 6480464 | aristolochic acid I results in decreased expression of RAI14 mRNA | CTD | PMID:33212167 | arsane | decreases expression | ISO | RGD:1314270 | 6480464 | Arsenic results in decreased expression of RAI14 mRNA | CTD | PMID:19654921 | arsane | multiple interactions | ISO | RGD:1314269 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA | CTD | PMID:32525701 | arsenic atom | decreases expression | ISO | RGD:1314270 | 6480464 | Arsenic results in decreased expression of RAI14 mRNA | CTD | PMID:19654921 | arsenic atom | multiple interactions | ISO | RGD:1314269 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA | CTD | PMID:32525701 | arsenite(3-) | increases methylation | ISO | RGD:1314269 | 6480464 | arsenite results in increased methylation of RAI14 promoter | CTD | PMID:23974009 | benzo[a]pyrene | multiple interactions | ISO | RGD:1314270 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to RAI14 promoter] | CTD | PMID:19654925 | benzo[a]pyrene | increases methylation | ISO | RGD:1314270 | 6480464 | Benzo(a)pyrene results in increased methylation of RAI14 exon, Benzo(a)pyrene results in increased methylation of RAI14 intron | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1314269 | 6480464 | Benzo(a)pyrene affects the methylation of RAI14 intron, Benzo(a)pyrene affects the methylation of RAI14 promoter | CTD | PMID:27901495, PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | RGD:1314269 | 6480464 | Benzo(a)pyrene results in decreased expression of RAI14 mRNA | CTD | PMID:20064835 | beta-naphthoflavone | decreases expression | ISO | RGD:1314269 | 6480464 | beta-Naphthoflavone results in decreased expression of RAI14 mRNA | CTD | PMID:32858204 | bis(2-chloroethyl) sulfide | affects expression | EXP | | 6480464 | Mustard Gas affects the expression of RAI14 mRNA | CTD | PMID:15651846 | bisphenol A | decreases expression | ISO | RGD:1314269 | 6480464 | bisphenol A results in decreased expression of RAI14 mRNA | CTD | PMID:25047013 | bisphenol A | increases expression | ISO | RGD:1314269 | 6480464 | bisphenol A results in increased expression of RAI14 protein | CTD | PMID:34186270 | bisphenol A | multiple interactions | ISO | RGD:1314269 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAI14 gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | ISO | RGD:1314269 | 6480464 | bisphenol A results in decreased methylation of RAI14 gene | CTD | PMID:31601247 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of RAI14 gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RAI14 mRNA | CTD | PMID:25181051 more ... | bisphenol A | increases expression | ISO | RGD:1314270 | 6480464 | bisphenol A results in increased expression of RAI14 mRNA | CTD | PMID:26063408 | Bisphenol B | increases expression | ISO | RGD:1314269 | 6480464 | bisphenol B results in increased expression of RAI14 protein | CTD | PMID:34186270 | bisphenol F | multiple interactions | ISO | RGD:1314269 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of RAI14 gene | CTD | PMID:31601247 | bisphenol F | increases expression | ISO | RGD:1314269 | 6480464 | bisphenol F results in increased expression of RAI14 protein | CTD | PMID:34186270 | caffeine | affects phosphorylation | ISO | RGD:1314269 | 6480464 | Caffeine affects the phosphorylation of RAI14 protein | CTD | PMID:35688186 | calcitriol | multiple interactions | ISO | RGD:1314269 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RAI14 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | RGD:1314269 | 6480464 | Calcitriol results in decreased expression of RAI14 mRNA | CTD | PMID:21592394 | CGP 52608 | multiple interactions | ISO | RGD:1314269 | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RAI14 gene] | CTD | PMID:28238834 | chloropicrin | decreases expression | ISO | RGD:1314269 | 6480464 | chloropicrin results in decreased expression of RAI14 mRNA | CTD | PMID:26352163 | cisplatin | decreases expression | ISO | RGD:1314269 | 6480464 | Cisplatin results in decreased expression of RAI14 mRNA | CTD | PMID:19561079 | cisplatin | multiple interactions | ISO | RGD:1314269 | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of RAI14 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | RGD:1314269 | 6480464 | cobaltous chloride results in decreased expression of RAI14 mRNA | CTD | PMID:19320972 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of RAI14 mRNA | CTD | PMID:24386269 | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of RAI14 mRNA | CTD | PMID:17898221 | copper(II) sulfate | increases expression | ISO | RGD:1314269 | 6480464 | Copper Sulfate results in increased expression of RAI14 mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | RGD:1314269 | 6480464 | coumarin affects the phosphorylation of RAI14 protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | RGD:1314270 | 6480464 | Asbestos, Crocidolite results in decreased expression of RAI14 mRNA | CTD | PMID:29279043 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of RAI14 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | RGD:1314269 | 6480464 | Cyclosporine results in decreased expression of RAI14 mRNA | CTD | PMID:22147139 | cyclosporin A | increases expression | ISO | RGD:1314269 | 6480464 | Cyclosporine results in increased expression of RAI14 mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of RAI14 mRNA | CTD | PMID:23914054 | decabromodiphenyl ether | increases expression | ISO | RGD:1314269 | 6480464 | decabromobiphenyl ether results in increased expression of RAI14 protein | CTD | PMID:31675489 | dexamethasone | decreases expression | ISO | RGD:1314269 | 6480464 | Dexamethasone results in decreased expression of RAI14 mRNA | CTD | PMID:25047013 | dibutyl phthalate | increases expression | ISO | RGD:1314270 | 6480464 | Dibutyl Phthalate results in increased expression of RAI14 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of RAI14 mRNA | CTD | PMID:21266533 | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RAI14 mRNA | CTD | PMID:33729688 | doxorubicin | decreases expression | ISO | RGD:1314269 | 6480464 | Doxorubicin results in decreased expression of RAI14 mRNA | CTD | PMID:29803840 | epoxiconazole | increases expression | ISO | RGD:1314270 | 6480464 | epoxiconazole results in increased expression of RAI14 mRNA | CTD | PMID:35436446 | fenthion | decreases expression | ISO | RGD:1314270 | 6480464 | Fenthion results in decreased expression of RAI14 mRNA | CTD | PMID:34813904 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of RAI14 mRNA | CTD | PMID:24793618 | folic acid | decreases expression | ISO | RGD:1314270 | 6480464 | Folic Acid results in decreased expression of RAI14 mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | RGD:1314270 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAI14 mRNA | CTD | PMID:22206623 | fulvestrant | multiple interactions | ISO | RGD:1314269 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAI14 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of RAI14 gene | CTD | PMID:31601247 | genistein | increases expression | ISO | RGD:1314270 | 6480464 | Genistein results in increased expression of RAI14 mRNA | CTD | PMID:32186404 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RAI14 mRNA | CTD | PMID:33387578 | gold atom | increases expression | ISO | RGD:1314269 | 6480464 | Gold results in increased expression of RAI14 mRNA | CTD | PMID:29705079 | gold(0) | increases expression | ISO | RGD:1314269 | 6480464 | Gold results in increased expression of RAI14 mRNA | CTD | PMID:29705079 | hydrogen peroxide | multiple interactions | ISO | RGD:1314270 | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | lead(0) | affects expression | ISO | RGD:1314269 | 6480464 | Lead affects the expression of RAI14 mRNA | CTD | PMID:28903495 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of RAI14 mRNA | CTD | PMID:22504374 | monosodium L-glutamate | decreases expression | ISO | RGD:1314270 | 6480464 | Sodium Glutamate results in decreased expression of RAI14 mRNA | CTD | PMID:22078008 | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of RAI14 mRNA | CTD | PMID:21515302 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RAI14 mRNA | CTD | PMID:25729387 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of RAI14 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | RGD:1314270 | 6480464 | Acetaminophen affects the expression of RAI14 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RAI14 mRNA | CTD | PMID:33387578 | paracetamol | affects expression | ISO | RGD:1314269 | 6480464 | Acetaminophen affects the expression of RAI14 mRNA | CTD | PMID:25704631 | paracetamol | increases expression | ISO | RGD:1314269 | 6480464 | Acetaminophen results in increased expression of RAI14 mRNA | CTD | PMID:22230336 | phenobarbital | affects expression | ISO | RGD:1314269 | 6480464 | Phenobarbital affects the expression of RAI14 mRNA | CTD | PMID:19159669 | phenobarbital | affects expression | ISO | RGD:1314270 | 6480464 | Phenobarbital affects the expression of RAI14 mRNA | CTD | PMID:23091169 | phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of RAI14 mRNA | CTD | PMID:18158353 | pirinixic acid | increases expression | ISO | RGD:1314270 | 6480464 | pirinixic acid results in increased expression of RAI14 mRNA | CTD | PMID:18301758 | potassium dichromate | increases expression | ISO | RGD:1314270 | 6480464 | Potassium Dichromate results in increased expression of RAI14 mRNA | CTD | PMID:23608068 | progesterone | multiple interactions | ISO | RGD:1314269 | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of RAI14 mRNA | CTD | PMID:20660070 | quercetin | increases expression | ISO | RGD:1314269 | 6480464 | Quercetin results in increased expression of RAI14 mRNA | CTD | PMID:21632981 | quercetin | increases phosphorylation | ISO | RGD:1314269 | 6480464 | Quercetin results in increased phosphorylation of RAI14 protein | CTD | PMID:35688186 | silicon dioxide | increases expression | ISO | RGD:1314269 | 6480464 | Silicon Dioxide analog results in increased expression of RAI14 mRNA | CTD | PMID:25895662 | sodium arsenate | increases expression | ISO | RGD:1314270 | 6480464 | sodium arsenate results in increased expression of RAI14 mRNA | CTD | PMID:21795629 | sodium arsenate | multiple interactions | ISO | RGD:1314269 | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA | CTD | PMID:32525701 | sunitinib | decreases expression | ISO | RGD:1314269 | 6480464 | Sunitinib results in decreased expression of RAI14 mRNA | CTD | PMID:31533062 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of RAI14 mRNA | CTD | PMID:21515302 | testosterone | multiple interactions | ISO | RGD:1314269 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RAI14 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | RGD:1314269 | 6480464 | Testosterone results in decreased expression of RAI14 mRNA | CTD | PMID:21592394 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RAI14 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RAI14 mRNA] | CTD | PMID:31150632 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RAI14 mRNA | CTD | PMID:34492290 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of RAI14 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of RAI14 mRNA | CTD | PMID:25729387 | topotecan | affects response to substance | ISO | RGD:1314269 | 6480464 | RAI14 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | triptonide | increases expression | ISO | RGD:1314270 | 6480464 | triptonide results in increased expression of RAI14 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:1314269 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of RAI14 mRNA | CTD | PMID:29024780 | troglitazone | decreases expression | ISO | RGD:1314270 | 6480464 | troglitazone results in decreased expression of RAI14 mRNA | CTD | PMID:28973697 | urethane | decreases expression | ISO | RGD:1314269 | 6480464 | Urethane results in decreased expression of RAI14 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | RGD:1314269 | 6480464 | Valproic Acid affects the expression of RAI14 mRNA | CTD | PMID:25979313 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of RAI14 mRNA | CTD | PMID:19015723 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RAI14 mRNA | CTD | PMID:23034163 | vitamin E | increases expression | ISO | RGD:1314269 | 6480464 | Vitamin E results in increased expression of RAI14 mRNA | CTD | PMID:19244175 | zoledronic acid | decreases expression | ISO | RGD:1314269 | 6480464 | zoledronic acid results in decreased expression of RAI14 mRNA | CTD | PMID:24714768 | |